摘要2023欧洲肿瘤内科学会年会(ESMO)于近日召开。此次会议对全球肿瘤学领域最前沿的研究进行了深入探讨，并发布了多项前列腺癌领域的重磅结果本文对其中根治手术后放疗的最佳时机、生化复发的新型药物治疗、转移性激素敏感性前列腺癌的疗效预测、以及骨保护剂应用的新价值等重要研究进行解读和点评，以期为临床治疗决策提供帮助。

abstractsThe 2023 European Society for Medical Oncology (ESMO) was held recently. In this conference, numbers of cutting-edge studies were discussed and published including advances in diagnosis and treatment, especially in prostate cancer. Studies that may influence clinical treatment decisions were summarized in this article, including timing of radiotherapy after radical prostatectomy, Enzalutamide in biochemically recurrent prostate cancer, predictive factors of novel hormonal therapies in metastatic hormone-sensitive prostate cancer, and the value of osteoprotective agent. The purpose of this article was to help clinicians make better clinical decisions.